These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22653882)

  • 41. New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma.
    Shirabe K; Toshima T; Kimura K; Yamashita Y; Ikeda T; Ikegami T; Yoshizumi T; Abe K; Aishima S; Maehara Y
    Liver Int; 2014 Jul; 34(6):937-41. PubMed ID: 24393295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum Insulin-Like Growth Factor-1 (IGF-1): a Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC).
    Yao Y; Mao W; Dong M; Yang D; Li W; Chen Y
    Clin Lab; 2017 Feb; 63(2):261-270. PubMed ID: 28182337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proper hepatic pedicle clamping during hepatectomy is associated with improved postoperative long-term prognosis in patients with AJCC stage IIIB hepatocellular carcinoma.
    Li X; Liu S; Li H; Guo L; Zhang B; Lin Z; Zhang J; Ye Q
    Oncotarget; 2016 Apr; 7(17):24623-32. PubMed ID: 27027437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The FIB-4 score predicts postoperative short-term outcomes of hepatocellular carcinoma fulfilling the milan criteria.
    Dong J; Xu XH; Ke MY; Xiang JX; Liu WY; Liu XM; Wang B; Zhang XF; Lv Y
    Eur J Surg Oncol; 2016 May; 42(5):722-7. PubMed ID: 26927299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LCSGJ-T classification, 6th or 5th edition TNM staging did not independently predict the long-term prognosis of HBV-related hepatocellular carcinoma after radical hepatectomy.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    J Surg Res; 2010 Mar; 159(1):538-44. PubMed ID: 19111323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10 cm or larger in diameter.
    Shimada K; Sakamoto Y; Esaki M; Kosuge T
    Langenbecks Arch Surg; 2008 Jul; 393(4):521-6. PubMed ID: 18188585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
    Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
    BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Impact of Serosal Invasion on Prognosis after Curative Hepatectomy for Hepatocellular Carcinoma: Invasion to Adjacent Organs and Rupture of Tumor Were Crucial Tumor-Related Prognostic Factors Needed for Survival.
    Kato Y; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
    Dig Surg; 2018; 35(2):155-163. PubMed ID: 28787731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
    Liu J; Zhu Q; Li Y; Qiao GL; Xu C; Guo DL; Tang J; Duan R
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):330-338. PubMed ID: 29551612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for extrahepatic metastases by additional staging modalities is required for hepatocellular carcinoma patients beyond modified UICC stage T1.
    Yi J; Gwak GY; Sinn DH; Kim YJ; Kim HN; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Hepatogastroenterology; 2013; 60(122):328-32. PubMed ID: 23241421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.
    Wang MD; Li C; Li J; Zhang WG; Jiang WQ; Yu JJ; Xing H; Wu H; Han J; Li ZL; Xu XF; Chen TH; Zhou YH; Gu WM; Wang H; Zeng YY; Zhang YM; Pawlik TM; Lau WY; Wu MC; Yang JM; Shen F; Yang T
    Oncologist; 2019 Aug; 24(8):e730-e739. PubMed ID: 31127021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.
    Hayashi M; Shimizu T; Hirokawa F; Inoue Y; Komeda K; Asakuma M; Miyamoto Y; Takeshita A; Shibayama Y; Tanigawa N
    Am Surg; 2011 May; 77(5):572-8. PubMed ID: 21679590
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of high serum testosterone levels on the long-term prognosis in male patients undergoing hepatectomy for early stage hepatocellular carcinoma without vascular invasion.
    Lin MC; Wu CC; Cheng SB; Liu TJ; P'eng FK
    World J Surg; 2007 Jul; 31(7):1469-73. PubMed ID: 17534543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
    Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
    [No Abstract]   [Full Text] [Related]  

  • 56. Long-term survival after partial hepatectomy for sub-stage patients with intermediate stage hepatocellular carcinoma.
    Wei WX; Yang ZS; Lu LH; Li J; Lei ZQ; Wang K; Xia Y; Yan ZL; Shen F
    Int J Surg; 2018 Aug; 56():256-263. PubMed ID: 29935368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.
    Zhao WC; Fan LF; Yang N; Zhang HB; Chen BD; Yang GS
    Eur J Surg Oncol; 2013 Aug; 39(8):858-64. PubMed ID: 23669199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single-center experience on actual mid-term (≥5 years) and long-term (≥10 years) survival outcome in patients with hepatocellular carcinoma after curative hepatectomy: A bimodal distribution.
    Fung AKY; Cheng NMY; Chong CCN; Lee KF; Wong J; Cheung SYS; Lok HT; Lai PBS; Ng KKC
    Medicine (Baltimore); 2020 Nov; 99(48):e23358. PubMed ID: 33235106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term outcomes after hepatectomy of huge hepatocellular carcinoma: A single-center experience in China.
    Fang Q; Xie QS; Chen JM; Shan SL; Xie K; Geng XP; Liu FB
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):532-537. PubMed ID: 31543313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery.
    Okamura Y; Ashida R; Yamamoto Y; Ito T; Sugiura T; Bekku E; Aramaki T; Uesaka K
    Langenbecks Arch Surg; 2016 Mar; 401(2):195-203. PubMed ID: 26943655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.